Liwei Meng
Impact in
- Molecular Medicine top 5%
- Curcumin's Biomedical Applications
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Circular RNAs in diseases 4
- Extracellular vesicles in disease 4
-
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 2
- Co-authors
- Yingchun Xu (4 shared papers)He Sun (2 shared papers)Shan Hu (2 shared papers)Liming Huang (3 shared papers)Li‐Min Huang (6 shared papers)Zhaoquan Xing (3 shared papers)Zhaoxu Liu (4 shared papers)Zhaoxin Guo (3 shared papers)
- Journals
- Aging (3 papers)Frontiers in Oncology (2 papers)Medicine (1 paper)Cell Death and Disease (1 paper)Frontiers in Ecology and Evolution (1 paper)
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Liwei Meng
18 papers receiving 382 citations
Peers
Comparison fields: 5 of 70
- Molecular Medicine 92
- Cancer Research 121
- Complementary and alternative medicine 40
- Toxicology 14
- Molecular Biology 222
Countries citing papers authored by Liwei Meng
This map shows the geographic impact of Liwei Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liwei Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liwei Meng more than expected).
Fields of papers citing papers by Liwei Meng
This network shows the impact of papers produced by Liwei Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liwei Meng. The network helps show where Liwei Meng may publish in the future.
Co-authors
The 25 scholars most cited alongside Liwei Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 155 | |
| 2 | 2015 | 72 | |
| 3 | 2020 | 33 | |
| 4 | 2021 | 29 | |
| 5 | 2019 | 27 | |
| 6 | 2020 | 13 | |
| 7 | 2014 | 11 | |
| 8 | 2021 | 11 | |
| 9 | 2021 | 11 | |
| 10 | 2023 | 10 | |
| 11 | 2022 | 4 | |
| 12 | 2019 | 4 | |
| 13 | 2023 | 2 | |
| 14 | 2022 | 2 | |
| 15 | 2025 | 1 | |
| 16 | 2023 | 1 | |
| 17 | [Horner's syndrome after central neck dissection in thyroid cancer: two cases report]. | 2011 | 1 |
| 18 | [Managements of small thyroid nodules with contralateral papillary thyroid microcarcinoma]. | 2012 | 1 |
| 19 | 2025 | 0 | |
| 20 | 2025 | 0 |
About Liwei Meng
Liwei Meng is a scholar working on Molecular Biology, Cancer Research, Surgery, Endocrinology, Diabetes and Metabolism and Immunology, having authored 20 papers that have together received 388 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Circular RNAs in diseases (4 papers), Extracellular vesicles in disease (4 papers), Cancer-related molecular mechanisms research (2 papers), Thyroid Cancer Diagnosis and Treatment (2 papers), Immune cells in cancer (2 papers), Urban Green Space and Health (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Molecular Medicine (92 citations), Cancer Research (121 citations), Complementary and alternative medicine (40 citations), Toxicology (14 citations) and Molecular Biology (222 citations). Liwei Meng has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Yingchun Xu, He Sun, Shan Hu, Liming Huang, Li‐Min Huang, Zhaoquan Xing, Zhaoxu Liu, Zhaoxin Guo, Wei Zhang and Yue Qiu. Their work appears in journals such as Aging, Frontiers in Oncology, Medicine, Cell Death and Disease and Frontiers in Ecology and Evolution.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.